Mural Oncology plc (MURA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MURA currently has 17.3M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 2.76% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 06, 2025 |
10-Q filing | 17.3M shares outstanding |
17M | 0 |
| Aug 04, 2025 |
10-Q filing | 17.3M shares outstanding |
17M | 0 |
| May 14, 2025 |
10-Q filing | 17.2M shares outstanding |
17M | 0 |
| Mar 11, 2025 |
10-K filing | 17.0M shares outstanding |
17M | 0 |
| Nov 13, 2024 |
S-3 filing: Mural Oncology PLC files an S-3 form to register debt securities, ordinary shares, preferred shares, and subscription rights, offering up to $300,000,000 in aggregate offering price. |
17M | 0 |
| Nov 13, 2024 |
10-Q filing | 17.0M shares outstanding |
17M | 0 |
| Aug 13, 2024 |
10-Q filing | 16.9M shares outstanding |
17M | 0 |
| May 14, 2024 |
10-Q filing | 16.8M shares outstanding |
17M | 0 |
| Mar 26, 2024 |
10-K filing | 16.7M shares outstanding |
17M | 0 |
| Dec 14, 2023 |
10-Q filing | 16.7M shares outstanding |
17M | 0 |